IRIS
RIPA, MARCO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 2.976
AS - Asia 2.204
NA - Nord America 2.079
SA - Sud America 423
AF - Africa 65
OC - Oceania 32
Continente sconosciuto - Info sul continente non disponibili 1
Totale 7.780
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.944
RU - Federazione Russa 1.709
CN - Cina 687
SG - Singapore 678
IT - Italia 404
BR - Brasile 319
SE - Svezia 294
HK - Hong Kong 287
VN - Vietnam 188
DE - Germania 128
GB - Regno Unito 105
FR - Francia 102
BD - Bangladesh 98
CA - Canada 84
IN - India 69
FI - Finlandia 43
AR - Argentina 41
PL - Polonia 39
AU - Australia 32
MX - Messico 32
NL - Olanda 32
JP - Giappone 31
AT - Austria 30
ES - Italia 25
TR - Turchia 20
ZA - Sudafrica 20
PK - Pakistan 17
SA - Arabia Saudita 17
ID - Indonesia 15
CO - Colombia 14
IQ - Iraq 14
EC - Ecuador 12
IR - Iran 12
TN - Tunisia 12
UA - Ucraina 12
CL - Cile 10
BE - Belgio 9
MA - Marocco 9
PH - Filippine 9
VE - Venezuela 9
PY - Paraguay 8
TW - Taiwan 8
AE - Emirati Arabi Uniti 7
EG - Egitto 7
IE - Irlanda 7
KR - Corea 7
LT - Lituania 7
LU - Lussemburgo 7
UZ - Uzbekistan 7
MY - Malesia 6
PT - Portogallo 6
UY - Uruguay 6
HR - Croazia 5
KE - Kenya 5
CY - Cipro 4
NI - Nicaragua 4
CH - Svizzera 3
HN - Honduras 3
IL - Israele 3
JM - Giamaica 3
JO - Giordania 3
LB - Libano 3
DO - Repubblica Dominicana 2
DZ - Algeria 2
MK - Macedonia 2
MN - Mongolia 2
NP - Nepal 2
PA - Panama 2
PE - Perù 2
QA - Qatar 2
TH - Thailandia 2
AM - Armenia 1
BG - Bulgaria 1
BH - Bahrain 1
BO - Bolivia 1
BW - Botswana 1
CG - Congo 1
CR - Costa Rica 1
CZ - Repubblica Ceca 1
ET - Etiopia 1
GA - Gabon 1
GD - Grenada 1
GT - Guatemala 1
GY - Guiana 1
HU - Ungheria 1
KZ - Kazakistan 1
LR - Liberia 1
MD - Moldavia 1
MU - Mauritius 1
NG - Nigeria 1
OM - Oman 1
PS - Palestinian Territory 1
RE - Reunion 1
RO - Romania 1
RS - Serbia 1
SC - Seychelles 1
SI - Slovenia 1
SV - El Salvador 1
SY - Repubblica araba siriana 1
TT - Trinidad e Tobago 1
Totale 7.778
Salva come PNG Salva come JPEG
Città #
Singapore 359
Moscow 313
Hong Kong 277
Ashburn 273
Dallas 235
San Jose 208
New York 140
Beijing 133
Shanghai 120
Milan 81
Hefei 78
Los Angeles 74
Lauterbourg 68
Ho Chi Minh City 66
Lawrence 60
Princeton 59
Boardman 48
São Paulo 44
Hanoi 38
Munich 38
Orem 36
Warsaw 33
Montreal 31
Santa Clara 30
Denver 28
Rome 28
Chennai 27
Tokyo 27
Helsinki 26
London 23
Nuremberg 21
Atlanta 20
Cesano Boscone 20
Houston 20
Poplar 20
Toronto 20
Genoa 19
Seattle 18
Brooklyn 17
Mexico City 17
Stockholm 17
Council Bluffs 16
Guangzhou 16
Rio de Janeiro 14
Turku 13
Da Nang 12
Chicago 11
Johannesburg 11
Manchester 11
Phoenix 11
Tianjin 11
Turin 11
Washington 11
San Francisco 10
Verona 10
Wollongong 10
Amsterdam 9
Boston 9
Falkenstein 9
Frankfurt am Main 9
Lahore 9
Mumbai 9
Naples 9
Ankara 8
Baghdad 8
Barnet 8
Brisbane 8
Huskvarna 8
Istanbul 8
Pietra Ligure 8
The Dalles 8
Vienna 8
Belo Horizonte 7
Brussels 7
Buffalo 7
Catania 7
Columbus 7
Curitiba 7
Kassel 7
Madrid 7
Sydney 7
Tashkent 7
Bogotá 6
Brasília 6
Haiphong 6
Melbourne 6
Montevideo 6
Pune 6
Querétaro 6
Riyadh 6
Bari 5
Calgary 5
Caruaru 5
Hangzhou 5
Jeddah 5
Miami 5
Nairobi 5
Padova 5
Quezon City 5
Santiago 5
Totale 3.691
Salva come PNG Salva come JPEG
Nome #
Outcomes of non-invasive ventilation as the ceiling of treatment in patients with COVID-19 241
Secondary infections in patients hospitalized with COVID-19: incidence and predictive factors 206
Viral clearance after early corticosteroid treatment in patients with moderate or severe covid-19 177
High Risk of Secondary Infections Following Thrombotic Complications in Patients With COVID-19 167
Clinical Features and Outcomes of Streptococcus anginosus Group Infective Endocarditis: A Multicenter Matched Cohort Study 156
Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS): Focus on the Pathophysiological and Diagnostic Role of Viruses 149
The place of ceftazidime/avibactam and ceftolozane/tazobactam for therapy of haematological patients with febrile neutropenia 146
48 week outcomes of maraviroc-containing regimens following the genotypic or Trofile assay in HIV-1 failing subjects: the OSCAR Study 145
Biobanking for COVID-19 research 145
Candidemia in COVID-19 patients: incidence and characteristics in a prospective cohort compared to historical non-COVID-19 controls 145
Efficacy and safety of tocilizumab in severe COVID-19 patients: a single-centre retrospective cohort study 143
Impact of Levofloxacin for Prophylaxis of Pre-engraftment Bloodstream Infections after Allogeneic HSCT: A single-center Matched Analysis in an Endemic Country for Carbapenem-resistant Gram-negative Bacteria 142
Levofloxacin prophylaxis vs no prophylaxis in neutropenic patients within an endemic country for carbapenem-resistant GNB 135
Trends of Antimicrobial Susceptibility of Neisseria gonorrhoeae Isolates between 2012 and 2023: Results from an Open Italian Cohort 132
Characteristics of HIV pre-exposure prophylaxis users at first PrEP counselling visit: the CSL-PrEP cohort 129
Clinical presentation, aetiology and outcome of infective endocarditis. Results of the ESC-EORP EURO-ENDO (European infective endocarditis) registry: A prospective cohort study 125
Publisher Correction: Viral clearance after early corticosteroid treatment in patients with moderate or severe covid-19 (Scientific Reports, (2020), 10, 1, (21291), 10.1038/s41598-020-78039-1) 125
Allogeneic bone marrow transplantation in HIV people with hematological malignancies: Post-transplant cyclophosphamide to overcome the HLA-matching barrier 124
High-Risk Neutropenic Fever and Invasive Fungal Diseases in Patients with Hematological Malignancies 122
One-Year Multidisciplinary Follow-Up of Patients With COVID-19 Requiring Invasive Mechanical Ventilation 121
Antibiotic appropriateness for Gram-negative bloodstream infections: impact of infectious disease consultation 118
Cardiac implantable electronic device infections: impact of initiation of antimicrobial treatment before or after device removal on microbiological yield 117
Circulating cathodic antigen (CCA) urine rapid test for diagnosis of Schistosoma mansoni infestation: preliminary data of a cohort study of Egyptian patients coming from an endemic area 113
Subclinical myocardial dysfunction in patients recovered from COVID-19 112
Cerebral thrombus analysis as a useful diagnostic tool for infective endocarditis in ischemic stroke patients 110
Post-neurosurgical Nocardia meningoventriculitis: a case report and review of the literature 110
Coronavirus Disease 2019 in Recipient of Allogeneic Hematopoietic Stem Cell Transplantation: Life-threating Features Within the Early Post-engraftment Phase 109
Clinical characteristics and outcome of infective endocarditis due to Abiotrophia and Granulicatella compared to Viridans group streptococci 107
High-dose anakinra in addition to standard of care including corticosteroids in patients with severe COVID-19 treated with non-invasive ventilation 104
Beneficial effects of cART initiated during primary and chronic HIV-1 infection on immunoglobulin-expression of memory B-cell subsets 102
The spectrum of covid-19-associated myocarditis: A patient-tailored multidisciplinary approach 101
Invasive fungal infections in patients with COVID-19: a review on pathogenesis, epidemiology, clinical features, treatment, and outcomes 101
Myocardial injury in patients with SARS-CoV-2 pneumonia: pivotal role of inflammation in COVID-19 100
Frailty as a predictor of mortality in COVID-19 patients receiving CPAP for respiratory insufficiency 100
Enhanced immunological recovery with early start of antiretroviral therapy during acute or early HIV infection–results of Italian network of acute HIV infection (Inaction) retrospective study 99
Use of Cefiderocol in Adult Patients: Descriptive Analysis from a Prospective, Multicenter, Cohort Study 98
The ESC-EORP EURO-ENDO (European Infective Endocarditis) registry 97
Ceftobiprole for the treatment of infective endocarditis: A case series 96
Combination of High-Dose Daptomycin and Ceftriaxone for Cardiac Implantable Electronic Device Infections: A 10-Year Experience 95
Role of Rehabilitation Department for Adult Individuals With COVID-19: The Experience of the San Raffaele Hospital of Milan 94
Infections after Allogenic Transplant with Post-Transplant Cyclophosphamide: Impact of Donor HLA Matching 93
Interleukin 1 blockade with high-dose anakinra in patients with COVID-19, acute respiratory distress syndrome, and hyperinflammation: a retrospective cohort study 92
Disseminated Mycobacterium chimaera infection favoring the development of Kaposi’s sarcoma: a case report 91
Comprehensive CT study to assess local and systemic involvement in patients with infective endocarditis: experience from a multidisciplinary team of a tertiary referral center 87
The Elephant in the Room: Secondary Infections and Antimicrobial Use in Patients With COVID-19 87
Predictors of survival in elderly patients with coronavirus disease 2019 admitted to the hospital: derivation and validation of the FLAMINCOV score 86
How do I manage a patient with Stenotrophomonas maltophilia infection? 83
Pulmonary Vascular Thrombosis in COVID-19 Pneumonia 83
Bowel perforation in a Covid-19 patient: case report 82
Genetic characterization of Klebsiella pneumoniae carbapenemase -producing Klebsiella pneumoniae isolates with different susceptibility to ceftazidime/avibactam in patients with blood-stream infections 81
Estimated glomerular filtration rate trajectories in HIV-infected subjects treated with different ritonavir-boosted protease inhibitors and tenofovir disoproxil fumarate or abacavir 72
Four-year outcome of a PI and NRTI-sparing salvage regimen: maraviroc, raltegravir, etravirine 70
Immunosenescence and hurdles in the clinical management of older HIV-patients 70
Is shorter duration of antibiotic treatment feasible in patients with cardiac implantable electronic device infections undergoing device removal? A propensity-adjusted analysis of a 10-year retrospective cohort 69
Time spent with residual viraemia after virological suppression below 50 HIV-RNA copies/mL according to type of first-line antiretroviral regimen 68
Dynamics of adaptive and innate immunity inpatients treated during primary human immunodeficiency virus infection: Results from Maraviroc in HIV Acute Infection (MAIN) randomized clinical trial 67
Influence of empirical double-active combination antimicrobial therapy compared with active monotherapy on mortality in patients with septic shock: A propensity score-adjusted and matched analysis 67
Maraviroc 150mg daily plus lopinavir/ritonavir, a nucleoside/nucleotide reverse transcriptase inhibitor-sparing regimen for HIV-infected naive patients: 48-week final results of VEMAN study 67
Durability of switch regimens based on rilpivirine or on integrase inhibitors, both in association with tenofovir and emtricitabine, in HIV-infected, virologically suppressed patients 66
LC-MS/MS method for simultaneous determination of linezolid, meropenem, piperacillin and teicoplanin in human plasma samples 66
Risk factors for Gram-negative bacterial infection of cardiovascular implantable electronic devices: multicentre observational study (CarDINe Study) 65
Eosinophils from Physiology to Disease: A Comprehensive Review 64
Short-term peripheral venous catheter-related bloodstream infections: Evidence for increasing prevalence of Gram-negative microorganisms from a 25-year prospective observational study 63
Multidrug-resistant bacterial colonization affects postoperative outcomes after pancreaticoduodenectomy 60
Viral rebound after switch to maraviroc/raltegravir dual therapy in highly experienced and virologically suppressed patients with HIV-1 infection 60
Evaluation of ceftazidime/avibactam for serious infections due to multidrug-resistant and extensively drug-resistant Pseudomonas aeruginosa 60
Homeostatic model assessment for insulin resistance index trajectories in HIV-infected patients treated with different first-line antiretroviral regimens 60
Real-life experience with remdesivir for treatment of COVID-19 among older adults: a multicentre retrospective study 60
Maraviroc in addition to cART during primary HIV infection: Results from MAIN randomized clinical trial and 96-weeks follow-up 57
Soluble endothelial protein C receptor (sEPCR) as an inflammatory biomarker in naive HIV-infected patients during ART 57
Impact of surgical timing on survival in patients with infective endocarditis: a time-dependent analysis 56
Usefulness of a hub and spoke TDM-guided expert clinical pharmacological advice program of dalbavancin for optimizing very long-term curative or suppressive treatment of chronic staphylococcal infections 55
Performance of commonly used genotypic assays and comparison with phenotypic assays of HIV-1 coreceptor tropism in acutely HIV-1-infected patients 55
Influence of empirical double-active combination antimicrobial therapy compared with active monotherapy on mortality in patients with septic shock: A propensity score-adjusted and matched analysis-authors' response 55
Pustulosis acuta generalisata following chemotherapy in an HIV-positive patient 54
Immunological Recovery After 24 Weeks of Antiretroviral Therapy in Patients With X4 Virus During Primary HIV Infection 53
Efficacy of elvitegravir/cobicistat/emtricitabine/tenofovir disoproxil fumarate as treatment for primary or recent HIV infection-authors' response 53
Cefiderocol therapy among immunocompromised adult patients: a descriptive analysis from a prospective, multicentre cohort study 52
Nailfold capillaroscopy findings in patients with coronavirus disease 2019: Broadening the spectrum of COVID-19 microvascular involvement. 52
Efficacy of elvitegravir/cobicistat/emtricitabine/tenofovir disoproxil fumarate as treatment for primary or recent HIV infection 51
Rugarli. Medicina interna sistematica 48
Invasive Pulmonary Aspergillosis Complicated by Carbapenem-Resistant Pseudomonas aeruginosa Infection During Pembrolizumab Immunotherapy for Metastatic Lung Adenocarcinoma: Case Report and Review of the Literature 47
Rugarli. Medicina interna sistematica 44
Bridging the gap in bloodstream infection management: A survey among non-infectious disease physicians 43
The INfectious DIsease REgistry BIObank (INDI-REBIO): protocol for the design and implementation of a single-centre, prospective registry and biobank in a tertiary care centre in Italy for advancing infectious disease research 31
Real-life use of high-dose anakinra in patients with COVID-19 treated with remdesivir 6
Regional sepsis care in Catalonia: comparative insights from a secondary analysis of the European Sepsis Care Survey 1
Monotherapy vs. combination therapy for Enterococcus faecalis bacteraemia: a target trial emulation 1
Totale 7.968
Salva come PNG Salva come JPEG
Categoria #
all - tutte 39.344
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 39.344
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022151 1 0 3 31 13 15 16 13 10 6 7 36
2022/2023482 136 113 22 9 20 63 16 52 14 10 17 10
2023/2024519 17 45 92 37 52 111 11 49 5 17 24 59
2024/20251.433 116 39 41 71 72 146 169 190 195 120 99 175
2025/20265.317 373 276 296 658 486 194 379 442 1.486 359 245 123
Totale 7.968